The DEA plans to reinstate federal requirements that patients see a doctor in person before receiving prescriptions for Schedule III drugs. During the declared COVID-19 public health emergency, the DEA had waived the requirement, but with the Biden Administration announcing it will end the public health emergency May 11, the DEA plans to end the […]